Literature DB >> 29102039

Improved Lymph Node Staging in Early-Stage Lung Cancer in the National Cancer Database.

Seth B Krantz1, Waseem Lutfi2, Kristine Kuchta3, Chi-Hsiung Wang3, Ki Wan Kim4, John A Howington5.   

Abstract

BACKGROUND: Lymph node assessment for non-small cell lung cancer (NSCLC) shows wide variation among centers. Our aim was to assess the quality of lymph node assessment in early-stage NSCLC and determine whether any factors are associated with improved lymph node harvest.
METHODS: We queried the National Cancer Database to identify patients with clinical stage I NSCLC who underwent segmentectomy or lobectomy between 2004 and 2013. Patients were stratified into three groups (≤5, 6 to 15, and >15) based on the number of lymph nodes assessed.
RESULTS: Patients (n = 51,358) met criteria, and mean lymph nodes assessed increased from 8.1 to 10.0 (p < 0.001) over the study period. There was a significant decrease in the percentage of patients with 0 to 5 nodes assessed (41.1% versus 31.1%, p < 0.001) and a significant increase in patients with more than 15 nodes assessed (10.1% versus 17.0%, p < 0.001). Patients at academic centers were less likely to have only 0 to 5 nodes assessed (27.2% versus 43.6% for community, p < 0.001). Variables associated with more than 15 nodes assessed were increasing year, age older than 65 years, male sex, non-African American race, academic centers, lobectomy, and clinical T2 disease. Patients with more than 14 nodes assessed demonstrated more nodal upstaging (17.9% versus 10.9% for 1 to 14 nodes, p < 0.001). Multivariable analysis suggests that at least 14 nodes should be assessed to maximize the probability that node-positive patients are correctly identified.
CONCLUSIONS: Lymph node assessment has improved since 2004 but varies by facility type and other characteristics. In our analysis removing at least 14 nodes was associated with more accurate staging.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29102039     DOI: 10.1016/j.athoracsur.2017.06.066

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  18 in total

1.  Adequacy of intra-operative nodal staging during lung cancer surgery: a poorly achieved minimum objective.

Authors:  Marc Riquet; Ciprian Pricopi; Giuseppe Mangiameli; Alex Arame; Alain Badia; Françoise Le Pimpec Barthes
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 2.  Early-Stage NSCLC: Advances in Thoracic Oncology 2018.

Authors:  Raymond U Osarogiagbon; Giulia Veronesi; Wentao Fang; Simon Ekman; Kenichi Suda; Joachim G Aerts; Jessica Donington
Journal:  J Thorac Oncol       Date:  2019-03-07       Impact factor: 15.609

3.  Oncologic validity of minimally invasive lobectomy for early stage lung cancer.

Authors:  Todd L Demmy; Sai Yendamuri
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

4.  Increasing T stage is associated with the need for more extensive lymph node assessment in clinical stage I non-small cell lung cancer.

Authors:  Andrew Brownlee; Seth B Krantz
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

Review 5.  Lymph node dissection during sublobar resection: why, when and how?

Authors:  Pascal-Alexandre Thomas
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 6.  Endobronchial ultrasound-transbronchial needle aspiration (EBUS/TBNA): a diagnostic challenge for mediastinal lesions.

Authors:  Duilio Divisi; Gino Zaccagna; Mirko Barone; Francesca Gabriele; Roberto Crisci
Journal:  Ann Transl Med       Date:  2018-03

7.  Persistence of racial disparities in early-stage lung cancer treatment.

Authors:  Andrea Wolf; Naomi Alpert; Benjamin V Tran; Bian Liu; Raja Flores; Emanuela Taioli
Journal:  J Thorac Cardiovasc Surg       Date:  2018-12-11       Impact factor: 5.209

8.  Preoperative Prediction of Lymph Node Metastasis in Patients With Early-T-Stage Non-small Cell Lung Cancer by Machine Learning Algorithms.

Authors:  Yijun Wu; Jianghao Liu; Chang Han; Xinyu Liu; Yuming Chong; Zhile Wang; Liang Gong; Jiaqi Zhang; Xuehan Gao; Chao Guo; Naixin Liang; Shanqing Li
Journal:  Front Oncol       Date:  2020-05-13       Impact factor: 6.244

9.  Lymph node upstaging for non-small cell lung cancer after uniportal video-assisted thoracoscopy.

Authors:  Mahmoud Ismail; Dania Nachira; Marc Swierzy; Gian Maria Ferretti; Julianna Paulina Englisch; Ramin Raul Ossami Saidy; Feng Li; Harun Badakhshi; Jens C Rueckert
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

Review 10.  18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of clinically node-negative non-small cell lung cancer.

Authors:  Yusuke Takahashi; Shigeki Suzuki; Noriyuki Matsutani; Masafumi Kawamura
Journal:  Thorac Cancer       Date:  2019-01-21       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.